NVO stock declines after a recent obesity study setback and intense competition from market rivals but offers long-term ...

Anavex Life Sciences remains one of the few non-amyloid Alzheimer's drug developers. Find out why I rate AVXL stock as a Hold ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story ...

However, smaller markets are most prone to capacity risk. Concentrated portfolios of small-cap or emerging-markets stocks are ...

Bitcoin has wobbled since breaching the $100,000 milestone earlier this month - but history suggests a new all-time high could be in sight by around mid-January, according to crypto research firm K33.

Singh took over as the finance minister when the economy was close to sovereign default, and completely altered its course ...

Manmohan Singh took over as the finance minister when the economy was close to sovereign default, and completely altered its ...

While valuations have been elevated throughout 2024, investors who avoided the stock market have likely paid a very high ...

Race is tackling the problem of chemo-induced heart damage – the clinicians’ key priority – with its reformulated drug ...

Biotech firm BioCorteX uses what may be the world’s largest biological knowledge graph to understand how bacteria impact the ...